18-Year Follow-Up After Coronary Stenting for Left Main Coronary Artery Lesions

Junqin Bai1, Zhichao Dong1, Lifei Pan1

  • 1Department of Cardiology, First Affiliated Hospital, Dalian Medical University.

International Heart Journal
|September 4, 2020
PubMed

Insights

Radiation-induced coronary artery disease (RCAD) treatment outcomes remain understudied. This case highlights successful coronary stenting in a patient with radiation-induced left main coronary artery lesions, despite neointimal proliferation.

Area of Science:

  • Cardiology
  • Oncology
  • Radiation Oncology

Background:

  • Radiation-induced coronary artery disease (RCAD) treatment outcomes require further investigation.
  • Patients with RCAD often lack traditional cardiovascular risk factors.
  • Mediastinal radiation therapy for lymphoma can lead to coronary artery lesions.

Observation:

  • The patient had received mediastinal radiation therapy (RT) at age 26 for Hodgkin lymphoma.
  • Initial treatment involved LMCA stenting, followed by balloon angioplasty at age 38 for in-stent stenosis.

Findings:

  • At age 51, the patient reported no chest pain, with coronary angiography showing no new lesions.
  • Optical coherence tomography revealed mild neointimal proliferation, calcific plaque, and uncovered stent struts, indicating residual disease despite clinical improvement.

Implications:

  • Coronary stenting can be a viable treatment option for radiation-induced coronary artery disease (RCAD) lesions.
  • This case provides valuable insights into the long-term management and potential complications of stenting in RCAD patients.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
96
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
114
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
93
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475